# Japanese Red Cross Nagoya Daini Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/japanese-red-cross-nagoya-daini-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 7 |
| Citations | 123,309 |
| City | Nagoya |
| Country | JP |
| Description | Japanese Red Cross Nagoya Daini Hospital is a research organisation in Nagoya, JP. OpenAlex records 2,672 works and 123,309 citations for it. 517 researchers list it as their most recent affiliation. |
| Homepage | http://www.nagoya2.jrc.or.jp/ |
| OpenAlex ID | https://openalex.org/I4210153328 |
| Researchers | 517 |
| ROR ID | https://ror.org/043pqsk20 |
| Type | healthcare |
| Works | 2,672 |

## University papers

- [Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients](https://scholariq.org/papers/quality-of-life-and-emotional-distress-in-peritoneal-dialysis-and-hemodialysis/)
- [Liraglutide relieves cardiac dilated function than <scp>DPP</scp>‐4 inhibitors](https://scholariq.org/papers/liraglutide-relieves-cardiac-dilated-function-than-scp-dpp-scp-4-inhibitors/)
- [Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury](https://scholariq.org/papers/vascular-endothelial-growth-factor-receptor-3-is-a-novel-target-to-improve-net/)
- [High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients](https://scholariq.org/papers/high-levels-of-soluble-c5b-9-complex-in-dialysis-fluid-may-predict-poor/)
- [Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy](https://scholariq.org/papers/expression-of-membrane-complement-regulators-cd46-cd55-and-cd59-in-mesothelial/)
- [Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment](https://scholariq.org/papers/impact-of-glucagon-like-peptide-1-receptor-agonist-and-sodium-glucose/)
- [Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal](https://scholariq.org/papers/anti-c5a-complementary-peptide-mitigates-zymosan-induced-severe-peritonitis-with/)
- [C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis](https://scholariq.org/papers/c1-inhibitor-mitigates-peritoneal-injury-in-zymosan-induced-peritonitis/)
- [Light Chain Deposition Disease Recurrence in Renal Allograft after Long-Term Remission](https://scholariq.org/papers/light-chain-deposition-disease-recurrence-in-renal-allograft-after-long-term/)
- [Higher dental care is positively associated with key prognosis factors in peritoneal dialysis patients: findings from a retrospective study](https://scholariq.org/papers/higher-dental-care-is-positively-associated-with-key-prognosis-factors-in/)

## University researchers

- [Daiki Iguchi](https://scholariq.org/researchers/daiki-iguchi/)

## University top topics

Showing 8 of 25.

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.